Related content

CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine

By Lin Keh-Ming   Tsou Hsiao-Hui   Tsai I-Ju   Hsiao Mei-Chun   Hsiao Chin-Fu   Liu Chia-Yih   Shen Winston W   Tang Hwa-Sheng   Fang Chun-Kai   Wu Chi-Shin   Lu Shao-Chun   Kuo Hsiang-Wei   Liu Shu Chih   Chan Hsiu-Wen   Hsu Ya-Ting   Tian Jia-Ni   Liu Yu-Li  

Pharmacogenomics, Vol. 11, Iss. 11, 2010-11 ,pp. : 1535-1543

Future Medicine

Access to resources Recommend Favorite

Genetic variation in androgen disposition: implications in clinical medicine including testosterone abuse

By Schulze Jenny J   Rane Anders   Ekström Lena  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 7, 2009-07 ,pp. : 731-744

Informa Healthcare

Access to resources Recommend Favorite

Genetic Variation of Human UDP-Glucuronosyltransferase: Implications in Disease and Drug Glucuronidation

By Burchell B.  

American Journal of PharmacoGenomics, Vol. 3, Iss. 1, 2003-01 ,pp. : 37-52

Adis International

Access to resources Recommend Favorite

Genetic Variation and Lactose Intolerance: Detection Methods and Clinical Implications

By Eric Sibley  

American Journal of PharmacoGenomics, Vol. 4, Iss. 4, 2004-01 ,pp. : 239-245

Adis International

Access to resources Recommend Favorite

Suicidal Ideation during Antidepressant Treatment: Do Genetic Predictors Exist?

By Perroud Nader  

CNS Drugs, Vol. 25, Iss. 6, 2011-06 ,pp. : 459-471

Adis International

Access to resources Recommend Favorite